Bone Marrow Transplantation News

Survivors of allogeneic hematopoietic cell transplantation who underwent high-dose total body irradiation incurred nearly eight times the risk for subsequent malignant neoplasms compared with the general population, according to study results published in Blood.

African American patients with multiple myeloma demonstrated superior OS compared with Caucasian patients in a VA setting with equal treatment access, according to a study published in Blood.

Increasing the dose of total body irradiation to 400 cGy from 200 cGy greatly reduced graft failure among patients with sickle cell disease or beta-thalassemia who received a haploidentical bone marrow transplant with post-transplantation cyclophosphamide, according to results of a phase 2 prospective study published in The Lancet Haematology.

Patients with cancer who need a bone marrow transplant are less likely to find a suitable match if they are of southern-European or non-European descent, according to results of a prospective study published in Blood Advances.

Carl H. June , MD, is about to receive an award for his life’s work — it's not his first and it certainly won’t be his last. Yet, he remains humble about the accolades.

Infants with newly diagnosed X-linked severe combined immunodeficiency, or SCID-X1, demonstrated multilineage engraftment of transduced cells after receiving lentiviral vector gene therapy and nonmyeloablative targeted busulfan conditioning, according to study findings published in The New England Journal of Medicine.

FORT WORTH, Texas — Ibrutinib treatment did not appear associated with increased incidence of fungal infections despite a low rate of antifungal prophylaxis among these patients, according to study results presented at HOPA Ahead 2019.

Roy L. Silverstein, MD, began his 1-year term as ASH president in January.

Infants with malignant diseases who underwent allogeneic hematopoietic stem cell transplantation did not demonstrate improved survival rates over a 15-year period, according to results of a study in JAMA Pediatrics.

Allogeneic hematopoietic stem cell transplantation did not significantly improve survival compared with chemotherapy alone among children with newly diagnosed hypodiploid acute lymphoblastic leukemia, according to results of a retrospective study published in Journal of Clinical Oncology.